Galectin Therapeutics Inc. (FRA:PHPN)
Germany · Delayed Price · Currency is EUR 4.780
0.00 (0.00%)
Last updated: Dec 1, 2025, 8:05 AM CET
Galectin Therapeutics Statistics
Total Valuation
FRA:PHPN has a market cap or net worth of EUR 305.58 million. The enterprise value is 406.00 million.
| Market Cap | 305.58M |
| Enterprise Value | 406.00M |
Important Dates
The last earnings date was Friday, November 21, 2025.
| Earnings Date | Nov 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 64.47M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +2.12% |
| Shares Change (QoQ) | +1.19% |
| Owned by Insiders (%) | 20.33% |
| Owned by Institutions (%) | 16.37% |
| Float | 45.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -2.90 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -12.72 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.09
| Current Ratio | 0.09 |
| Quick Ratio | 0.08 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.10 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -87.09% |
| Return on Invested Capital (ROIC) | -213.11% |
| Return on Capital Employed (ROCE) | 23.59% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -2.13M |
| Employee Count | 15 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +84.21% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +84.21% |
| 50-Day Moving Average | 4.30 |
| 200-Day Moving Average | 2.59 |
| Relative Strength Index (RSI) | 53.80 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 19.41 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -24.84M |
| Pretax Income | -31.79M |
| Net Income | -31.91M |
| EBITDA | n/a |
| EBIT | -24.84M |
| Earnings Per Share (EPS) | -0.50 |
Balance Sheet
The company has 9.82 million in cash and 107.44 million in debt, giving a net cash position of -97.61 million.
| Cash & Cash Equivalents | 9.82M |
| Total Debt | 107.44M |
| Net Cash | -97.61M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -105.33M |
| Book Value Per Share | -1.66 |
| Working Capital | -105.44M |
Cash Flow
| Operating Cash Flow | -26.10M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FRA:PHPN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.12% |
| Shareholder Yield | -2.12% |
| Earnings Yield | -10.44% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 23, 2012. It was a reverse split with a ratio of 0.1666666667.
| Last Split Date | Mar 23, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.1666666667 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |